QMS Medical Allied Services Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Attractively valued vs sector (P/E 35.2x vs industry 50.2x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
QMSMEDI · as of Jun 2026
| Category | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 73.67% | 73.67% | 73.67% | 73.67% | 73.67% | 68.11% |
| FII | 1.02% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| DII | — | — | — | — | — | 1.60% |
| Public | 25.32% | 26.33% | 26.33% | 26.33% | 26.33% | 30.28% |
Latest News
All newsQMS Medical acquires Saarathi Healthcare in full.
*QMS Medical acquires Saarathi Healthcare in full.* QMS Medical Allied Services Limited announced the completion of its **100% acquisition** of Saarathi Healthcare Pvt Ltd, effective September 18, 2026. The deal strengthens QMS Medical’s presence in the healthcare services sector through expanded infrastructure and patient networks. Financial terms were not disclosed. 📊 *STOCKS:* QMSMEDICAL | 🏢 *SECTOR:* Corporate | #HIGHIMPACT #Acquisition
QMS Medical to acquire Pune-based deep-tech firm Beamoptics
*QMS Medical to acquire Pune-based deep-tech firm Beamoptics* — The company announced the acquisition of Beamoptics Scientific, a diagnostics and analytical deep-tech firm. This strategic move expands QMS Medical’s footprint in the scientific healthcare space. The deal underscores growth ambitions in high-tech diagnostics. 📊 *STOCKS:* $QMSMEDICAL | 🏢 *SECTOR:* Healthcare | #MEDIUMIMPACT #Acquisition
QMS Medical bags exclusive India rights for HEINE diagnostics
*QMS Medical bags exclusive India rights for HEINE diagnostics.* The company signed a five-year agreement with HEINE Optotechnik, a global leader in primary diagnostic instruments, for exclusive marketing and distribution rights in India. This partnership expands QMS Medical's presence in the diagnostic equipment space. The move is expected to boost revenue streams over the contract period. 📊 *STOCKS:* $QMSMEDICAL | 🏢 *SECTOR:* Corporate | #MEDIUMIMPACT #DistributionDeal
QMS Medical Allied to hold shareholder meeting on Sept 30, 2026
*QMS Medical Allied to hold shareholder meeting on Sept 30, 2026.* The company has scheduled a meeting of shareholders on **September 30, 2026**, as per a corporate filing. Purpose of the meeting is not detailed in the notice. It may involve resolutions related to routine corporate matters or disclosures. 📊 *STOCKS:* $QMSMEDICAL | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #ShareholdersMeeting
Health Care At Home merges pharma business with QMS Medical
*Health Care At Home merges pharma business with QMS Medical.* The two companies have combined their pharmaceutical operations to streamline growth and improve market reach. The move is expected to enhance operational efficiency and reduce duplication. Financial terms, including the valuation of the merged entity, were not disclosed. 📊 *STOCKS:* HCAM, QMS | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Pharma